Tag:
SCOLR Pharma
Latest Headlines
Latest Headlines
FDA scolds SCOLR for deficient ANDA filing
Bothell, WA-based SCOLR Pharmaceuticals has been scolded by the FDA for an inadequate Abbreviated New Drug Application for extended-release pseudoephedrine. According to SCOLR, the regulatory
